Experience behind the capability
The operating experience behind Lampgen.
Founder Tommy Lampley Jr.’s work in site monitoring and sponsor-side study management informs how Lampgen evaluates talent, diagnoses execution gaps, and scopes oversight.
TL
01 ORIGIN
From site monitoring to sponsor-side operations.
Lampgen Clinical Research LLC was formed in Georgia on April 18, 2014. In 2015, Lampgen developed business plans for clinical trial site operations. Today, Lampgen offers clinical operations advisory, managed monitoring, and staffing to oncology sponsors and CROs.
Founder Tommy Lampley, Jr.’s professional experience includes Lead CRA responsibilities, clinical trial management, sponsor oversight, and global study operations.
That experience informs how Lampgen evaluates talent, anticipates execution risk, and aligns clinical-operations professionals to the realities of an assignment.
HOW THAT EXPERIENCE BECAME SIGNAL™
From reviewing sites to seeing across a study.
Tommy’s work as a CRA, Lead CRA, and study manager shaped how Lampgen evaluates clinical judgment. SIGNAL™ turns that perspective into a repeatable method for investigating findings, deciding what to escalate, and checking whether a corrective action worked.
Explore the SIGNAL™ framework →